Immunizations/Delivery 2

Immunizations/Delivery 2

676 - A Randomized Controlled Trial of Enhanced Outreach to Increase COVID-19 Vaccination for Children with Chronic Health Conditions from Under Resourced Communities​

677 - Association between Medicaid Expansion and early childhood immunization rates using the National Immunization Survey-Child, 2012-2019.

678 - Bacille Calmette Guérin (BCG) and Hepatitis B vaccine (HBV) induce distinct changes in the human neonatal plasma metabolome

679 - Changing the Age of Routine HPV Vaccination Initiation to 9-10 years: Experiences of Clinicians

680 - Characteristics and Vaccination Patterns of U.S. Children Who Did Not Receive Routine Measles-Mumps-Rubella Vaccination, National Immunization Survey-Child, 2011-2022

682 - Did COVID-19 Affect Pediatric Immunization Rates?

683 - Examining Parent, Child, and Provider Experiences with Early Childhood Immunization for an HPV Vaccine Trial Among Four to Eight-Year-Olds: A Mixed Methods Study

684 - Factors Associated with Nirsevimab Receipt for Respiratory Syncytial Virus Prophylaxis Among Asian and Pacific Islander Infants in Hawaii

685 - Human in vitro modeling determines the immunogenicity of vaccine adjuvant formulations in children

686 - Key determinants for inpatient vaccine delivery at 11 US Children’s Hospitals

688 - Neonatal Vaccination: A Ten-Year Retrospective Study in a Large Delivery Center

689 - Risk of Febrile Seizures following Measles Vaccination Among Children 6-59 months in a Federally Qualified Health Care System, 2008-2024

690 - RSV Protection for Neonates Before Hospital Discharge